FDA recall, , Low risk
American National Red Cross Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were distributed without a visual inspection.
Recall ended Mar 27, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross recalled Apheresis Red Blood Cells, Leukocytes Reduced, because a visual inspection was not performed or documented for the distributed product. The recall began on February 24, 2025, and was added to the FDA's Enforcement Report on March 27, 2026. The affected product was distributed in California.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Red Blood Cells, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- American National Red Cross (the)
- Hazard
- Quality testing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 98448
- Recall number
- B-0048-2026
All recalls from American National Red Cross (the)
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Archived
